Tuesday, 22 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14455
Articles
Company
Deals
HitGen Inc. Forms Strategic Partnership for New Drug Research and Development
March 26, 2025
Company
Drug
Yabao Pharmaceutical’s YBSW015 Gets Australian Ethical Approval for COVID-19 Trial
March 26, 2025
Drug
Suzhou Zelgen’s JAK Inhibitor Jacktinib Gets NMPA Green Light for COVID-19 Trial
March 26, 2025
Company
Drug
Sichuan Kelun’s KL340399 Wins NMPA Approval for Solid Tumor Trials
March 26, 2025
Company
Deals
WinHealth Pharma and Ferring Partner to Co-Promote Pentasa in China
March 26, 2025
Company
Deals
WuXi ATU Partners with Wugen to Accelerate NK Cell Therapy Development
March 26, 2025
Company
Drug
Jiangsu Hengrui Medicine’s SHR4640 Receives NMPA Approval for Gout Trial
March 26, 2025
Company
Drug
Beijing Aosaikang’s ASKG315 Receives NMPA Approval for Solid Tumor Trial
March 26, 2025
Company
Deals
Jacobson Pharma Leads HKD 6 Million JV for Specialty Drug Distribution
March 26, 2025
Company
Drug
Hansoh Pharmaceutical’s Ameile Accepted for UK Regulatory Review
March 26, 2025
Company
Deals
MegaRobo Secures USD 300 Million in Series C Round Led by Goldman Sachs
March 26, 2025
Policy / Regulatory
China Issues Monkeypox Diagnosis Guidelines Amid Global Outbreaks
March 26, 2025
1
2
…
1,197
1,198
1,199
1,200
1,201
…
1,204
1,205
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?